Navigation Links
Susan G. Komen for the Cure(R) Announces Largest Grants Slate Ever: $100 Million to Speed Delivery of Breast Cancer Discoveries, Cures
Date:4/21/2008

'Promise Grants' Offer Individuals, Corporations Unique Opportunities to

Invest in Significant Collaborative Research Ventures

DALLAS, April 21 /PRNewswire/ -- Susan G. Komen for the Cure(R), the world's largest breast cancer organization, today announced the awarding of more than $100 million in research grants, representing the largest single-year investment in research in the organization's 26-year history and a 30 percent increase over last year's award total of $77 million. The 2008 grants slate moves Komen for the Cure closer to accomplishing its goal of investing another $2 billion in breast cancer research and community health programs by 2017.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070122/NYM084LOGO)

With this year's slate of 143 grants, Komen for the Cure has fully activated new funding mechanisms designed to speed the discovery and delivery of the cures for breast cancer. The 2008 slate funds projects designed to promote breast cancer research collaboration and cost efficiencies, arrive at reliable and replicable research results more quickly, motivate bright young investigators to commit to breast cancer research careers and keep career researchers intensely focused on breast cancer.

"We've made it clear that our money will fund projects that focus on ways to significantly reduce breast cancer incidence and mortality within the next ten years," said Susan G. Komen for the Cure President and CEO Hala Moddelmog.

Specifically, Komen for the Cure is funding research initiatives exploring key breast cancer issues, including genetic risks, risk modulation, breast cancer stem cells, new targets for breast cancer therapies, therapeutic vaccines, treatment resistance, the molecular basis for chemotherapeutic response, strategies for the reduction of tumor progression, the role of micro-environments, the role of specific pr
'/>"/>

SOURCE Susan G. Komen for the Cure
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Susan G. Komen for the Cure Announces Recipients of 2007 Komen Brinker Award for Scientific Distinction
2. Cell Therapeutics, Inc. Announces Receipt of Letter From the NASDAQ Stock Market Regarding Non-Compliance With the Minimum Bid Price Requirement
3. US Oncology Announces Resignation of Chief Financial Officer
4. Biotherm Announces a Unique Dermobiotic Three-Step Anti-Cellulite Slimming Treatment
5. Osteotech Announces First Quarter Earnings Release and Conference Call Schedule
6. ARUP Laboratories CEO and Co-Founder Announces Retirement
7. Gene Network Sciences Names New CSO and Announces New Scientific Advisory Board
8. Victhom announces promising results on the proof of concept for its unique closed-loop neuromodulation system
9. Oncolytics Biotech Inc. Announces Gene Therapy Publication on Reovirus Treatment for Melanoma
10. EMD Serono Announces Planned Investment of $50 Million in Research Center in Massachusetts
11. Angiotech announces director resignation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... Ottawa, Ontario (PRWEB) November 27, 2014 ... Korean Ministry of Food and Drug Safety (MFDS) regulatory ... The system provides genetic results in less than 60 ... system is indicated as an aid for doctors to ... 2C19 genetic pathway. These include some of the world’s ...
(Date:11/26/2014)... 26, 2014 Publicis Healthcare Communications Group ... the organization has won a total of 20 awards ... LifeBrands was honored with a Silver Award and 11 ... eight Awards of Excellence. , The Annual Rx ... and promotion. The Awards provide a forum for the ...
(Date:11/26/2014)... In keeping with the holiday spirit, ... of last-minute Thanksgiving savings. The company is offering up ... product lines this holiday weekend as well as a ... and Cyber Monday are right around the corner, and ... loyal customers and those looking to explore their ancestry, ...
(Date:11/26/2014)... November 26, 2014 On January, 14, ... Baltimore and Washington D.C. science community to the UMBC ... event, sponsored by the Protein Society, will take place ... Center, Room 312. Through discussion, presentations and workshops, ... importance of proteins, their role in the industry and ...
Breaking Biology Technology:Spartan Bioscience Receives Korean Regulatory Approval for First Rapid DNA Test of Mutations Affecting Metabolism of Common Drugs 2Spartan Bioscience Receives Korean Regulatory Approval for First Rapid DNA Test of Mutations Affecting Metabolism of Common Drugs 3Publicis Healthcare Wins 20 Rx Club Awards 2Publicis Healthcare Wins 20 Rx Club Awards 3DNA Spectrum Offers Last Minute Thanksgiving Coupons 2DNA Spectrum Offers Last Minute Thanksgiving Coupons 3
... Mass., March 19 Biopure,Corporation (Nasdaq: ... Kingdom,s,Medicines and Healthcare products Regulatory Agency (MHRA) ... manufacturing facility. The,inspection report contained no "Critical" ... manufacturing practices. The MHRA report identified,shortcomings characterized ...
... 19 AdvanDx announced it received,Frost & ... Award in the,field of rapid in-vitro molecular ... on AdvanDx,s easy-to-use, molecular-based,PNA FISH(TM) diagnostics to ... days. The rapid PNA FISH results enable ...
... MacroChem,Corporation (OTC Bulletin Board: MACM) today announced ... of Chief Financial Officer, effective,immediately. Mr. Luci has ... Development since joining the Company in December,2007., ... Inc. prior to its,successful merger transaction with Genzyme ...
Cached Biology Technology:Biopure Completes U.K. Regulatory Agency Inspection 2AdvanDx Receives Frost & Sullivan's Rapid In-Vitro Diagnostic Technology Innovation of the Year Award 2AdvanDx Receives Frost & Sullivan's Rapid In-Vitro Diagnostic Technology Innovation of the Year Award 3AdvanDx Receives Frost & Sullivan's Rapid In-Vitro Diagnostic Technology Innovation of the Year Award 4MacroChem Appoints David P. Luci as New CFO 2MacroChem Appoints David P. Luci as New CFO 3
(Date:11/4/2014)... 2014 – University of Utah engineers developed the first ... fuel produce electricity without needing to ignite the fuel. ... portable electronics, off-grid power and sensors. , A study ... American Chemical Society journal ACS Catalysis . , ... reaction between a fuel and an oxygen-rich source such ...
(Date:11/4/2014)... Think about the way our bodies are assembled during ... that they are supposed to become a nerve or ... the correct place and alignment? Researchers at the University ... In a new study, UM researchers describe the signaling ... neighbors, at the head-trunk region. Their discovery may have ...
(Date:11/4/2014)... A majority of Madagascar,s 101 species of lemurs are ... for the rainforests they call home. A new study ... can have on rainforest tree populations, which raises concerns ... the region,s rich biodiversity. , A large proportion of ... Lemurs in turn disperse the seeds of their ...
Breaking Biology News(10 mins):Jet-fueled electricity at room temperature 2The inside story: How the brain and skull stay together 2Gardeners of Madagascar rainforest at risk 2Gardeners of Madagascar rainforest at risk 3
... engineer has been awarded a $394,300 grant from the ... flow in the new facilities of the 150-mile Integrated ... of civil engineering, will investigate the best methods and ... effort to eliminate biological growths in the new pump ...
... awarded $12.7 million to match nine academic research ... to explore new treatments for patients in eight ... and schizophrenia. The collaborative pilot initiative, called Discovering ... by the National Center for Advancing Translational Sciences ...
... 10% of breast and ovarian cancers are familial in ... attributable to inherited mutations from the parents in genes ... mutations, PARP inhibitors, which are currently in clinical trials, ... option for personalised cancer treatment, an alternative to standard ...
Cached Biology News:UT Arlington research to benefit quality, flow in 150-mile Integrated Pipeline 2NIH to fund collaborations with industry to identify new uses for existing compounds 2NIH to fund collaborations with industry to identify new uses for existing compounds 3NIH to fund collaborations with industry to identify new uses for existing compounds 4An article in 'Cell' reveals a new resistance mechanism to chemotherapy in breast and ovarian cancer 2
Alpha-2-antiplasmin precursor (Alpha-2-plasmin inhibitor) (Alpha-2-PI) (Alpha-2-AP). [Source:Uniprot/SWISSPROT;Acc:P08697] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Mouse polyclonal antibody raised against a partial recombinant CSRP3. NCBI Entrez Gene ID = 8048...
Mouse monoclonal antibody raised against a partial recombinant EOMES. NCBI Entrez Gene ID = EOMES...
...
Biology Products: